Critical insights into the evolving drug-approval process in China.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38165313.
- Also identified by DOI 10.1002/cncr.35186 and PMC identifier 10922387.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Efforts have been put forward to improve the therapeutic development process in China and more novel therapies have been approved in recent years. It is important to develop and test novel therapies in China given differences in metabolism and tolerance compared to other populations.
Medical subject headings
- Drug Approval